OBJECTIVE: Chronic methamphetamine (MA) use is associated with moderate deficits in learning and memory, but the extend to which MA users are aware of such memory deficits (i.e., metamemory) is not known. METHODS: In the current study, 195 participants with lifetime MA use diagnoses (MA +) and 195 non-MA-using comparison subjects (MA -) underwent comprehensive neuropsychiatry research assessments, including performance-based and self-report measures of episodic memory. RESULTS: MA use disorders, major depressive disorder (MDD), and their interaction were uniquely associated with metamemory functioning, such that MDD increased the likelihood of a metamemory deficit among MA + participants. Within the MA group, individuals who over-estimated their memory abilities demonstrated greater executive dysfunction and lower cognitive reserve. CONCLUSIONS: Chronic MA use is associated with reduced awareness of objective deficits in memory acquisition and recall, which is particularly exacerbated by the presence of major depression. Efforts to enhance metamemory accuracy and deployment of compensatory mnemonic strategies may benefit substance abuse treatment outcomes.
OBJECTIVE: Chronic methamphetamine (MA) use is associated with moderate deficits in learning and memory, but the extend to which MA users are aware of such memory deficits (i.e., metamemory) is not known. METHODS: In the current study, 195 participants with lifetime MA use diagnoses (MA +) and 195 non-MA-using comparison subjects (MA -) underwent comprehensive neuropsychiatry research assessments, including performance-based and self-report measures of episodic memory. RESULTS: MA use disorders, major depressive disorder (MDD), and their interaction were uniquely associated with metamemory functioning, such that MDD increased the likelihood of a metamemory deficit among MA + participants. Within the MA group, individuals who over-estimated their memory abilities demonstrated greater executive dysfunction and lower cognitive reserve. CONCLUSIONS: Chronic MA use is associated with reduced awareness of objective deficits in memory acquisition and recall, which is particularly exacerbated by the presence of major depression. Efforts to enhance metamemory accuracy and deployment of compensatory mnemonic strategies may benefit substance abuse treatment outcomes.
Authors: Steven Paul Woods; Julie D Rippeth; Emily Conover; Assawin Gongvatana; Raul Gonzalez; Catherine L Carey; Mariana Cherner; Robert K Heaton; Igor Grant Journal: Neuropsychology Date: 2005-01 Impact factor: 3.295
Authors: Julie D Rippeth; Robert K Heaton; Catherine L Carey; Thomas D Marcotte; David J Moore; Raul Gonzalez; Tanya Wolfson; Igor Grant Journal: J Int Neuropsychol Soc Date: 2004-01 Impact factor: 2.892
Authors: Kaitlin B Casaletto; David J Moore; Steven Paul Woods; Anya Umlauf; J C Scott; Robert K Heaton Journal: Clin Neuropsychol Date: 2016-01-12 Impact factor: 3.535
Authors: Marilyn Huckans; Stephen Boyd; Grant Moncrief; Nathan Hantke; Bethany Winters; Kate Shirley; Emily Sano; Holly McCready; Laura Dennis; Milky Kohno; William Hoffman; Jennifer M Loftis Journal: J Clin Exp Neuropsychol Date: 2021-10-06 Impact factor: 2.283
Authors: Paula L Vieira-Brock; Lisa M McFadden; Shannon M Nielsen; Misty D Smith; Glen R Hanson; Annette E Fleckenstein Journal: Int J Neuropsychopharmacol Date: 2015-07-11 Impact factor: 5.176
Authors: Samantha J Brooks; L Wiemerslage; K H Burch; S A Maiorana; E Cocolas; H B Schiöth; K Kamaloodien; D J Stein Journal: Psychopharmacology (Berl) Date: 2017-03-21 Impact factor: 4.530
Authors: Rebecca McKetin; Janni Leung; Emily Stockings; Yan Huo; James Foulds; Julia M Lappin; Craig Cumming; Shalini Arunogiri; Jesse T Young; Grant Sara; Michael Farrell; Louisa Degenhardt Journal: EClinicalMedicine Date: 2019-10-17